Progyny, Inc.
NASDAQProgyny enters the back half of August in a fundamentally different position than it occupied a week ago — a bruising post-earnings selloff has wiped out months of gains and forced a rapid reassessment across the Street. The catalyst is clear. Progyny reported Q2 results on August 6 and the stock fell more than 10% the following session. That single-day drop accounts for most of…
Snapshot as of 30 Aug 2026
Progyny enters the back half of August in a fundamentally different position than it occupied a week ago — a bruising post-earnings selloff has wiped out months of gains and forced a rapid reassessment across the…
Progyny enters its August 6 earnings window with an unusual combination: a stock up 21% over the past month, a wall of analyst upgrades behind it, and options traders showing a rare spike in defensive positioning — all…
Progyny heads into its May 21 earnings report with options market positioning sending one of its most bullish signals of the past year — a stark contrast to the cautious tone that dominated the stock through most of…
Progyny reports Q1 2026 results on May 8 carrying options skew that has turned more defensive, against a backdrop of short sellers who have meaningfully reduced their bets — a split signal ahead of a stock that last…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PGNY — free to start on ORTEX.
Sign up for free →Open PGNY on ORTEX